Insurers will face a flood of pandemic-related claims after an appeals court ruled in a test case brought by the Insurance Council that certain infectious disease exclusions in business interruption cover do not apply to coronavirus-related claims.
A former executive of a unit of Leighton Holdings has been arrested and charged with foreign bribery offences following a 9 year-investigation by the AFP into $106 million in bribes allegedly steered to Iraqi officials to win lucrative oil projects.
Two more law firms have been joined to a lawsuit by defunct financial advisor Dover Financial accusing three law firms of providing negligent advice regarding an inaptly titled client protection policy which a judge found was “highly misleading” and “an exercise in Orwellian doublespeak”.
Epic Games, maker of the popular Fortnite game, has taken its courtroom battle with Apple to Australia, hitting the tech giant with a lawsuit for allegedly abusing its market power.
Insurer Liberty Mutual is challenging its loss in a coverage dispute with construction company Icon Co over $31 million in losses stemming from Sydney’s Opal Tower, whose residents were evacuated after cracks appeared in the tower’s walls on Christmas Eve in 2018.
A former director of defunct financial services company Linchpin Capital, who is facing a class action as well as civil penalty proceedings by ASIC, can’t put the brakes on his challenge to a five-year disqualification order by the regulator.
Class action filings in the Victoria Supreme Court have more than doubled in 2020, a trend that’s likely to hold as law firms take advantage of a new law allowing them to earn contingency fees for running successful class actions.
A McDonald’s franchisee has been ordered to pay $82,000 in penalties for systemically denying workers drink and toilet breaks and misleading them about their break entitlements, providing fuel for a class action investigation into the US fast food chain for allegedly denying workers rest breaks.
A judge has dismissed Pfizer’s bid for preliminary discovery to pursue a possible patent infringement case against drug maker Sandoz over a generic version of its blockbuster rheumatoid arthritis biologic Enbrel.
The High Court won’t wade into Kraft-Heinz’s intellectual property dispute with Bega after the US food giant came up short twice its battle over the right to use its peanut butter trade dress in Australia.